Fatty liver disease is often linked to obesity, but millions of lean people also develop it unnoticed, making its root causes a mystery. To solve this puzzle, Dr. Charles Brenner, head of the Diabetes and Cancer Metabolism Program at City of Hope, studied citrin deficiency as a model. CD patients share two curious traits: they remain lean yet have fatty livers, and they instinctively avoid sweets and alcohol. Brenner’s team suspected the liver’s stress response might drive both effects.
Using molecular and metabolic models, researchers discovered that when the liver lacks citrin, levels of the molecule glycerol 3 phosphate (G3P) surge. This buildup activates ChREBP, a protein that flips on genes responsible for producing and storing fat, effectively programming the liver to accumulate rather than burn fat. At the same time, G3P acts as a stress signal that triggers higher levels of FGF21, a hormone known to suppress cravings for sugar and alcohol while promoting fat metabolism.
The dual action of G3P—fueling fat buildup but also prompting hormonal self correction-helps explain why lean people with CD develop fatty livers yet shun sweet foods. It also provides a missing link between metabolic stress, diet behavior, and liver health.
These findings point to promising therapeutic targets. Drugs that block the G3P–ChREBP pathway could reduce fat synthesis in the liver, while G3P based or FGF21 mimicking therapies might help regulate appetite and enhance fat burning. “By understanding how metabolism goes awry, we can design smarter ways to restore balance,” said Dr. Brenner.
With fatty liver disease now affecting over a billion people globally, this discovery could reframe how researchers—from metabolic biology to nutrition science—approach one of today’s fastest growing health crises.
REFERENCE: Tiwari, V., et al. (2025). Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency. Nature Metabolism. DOI: 10.1038/s42255-025-01399-3. https://www.nature.com/articles/s42255-025-01399-3
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.